RxDoctor Payments Data

Paul Williams

Family · Vandalia, ILNPI 1982964508

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 31.5% of the total. Reporting peaked in 2021 at $1,487 and has fallen 94.6% since, to $80 in 2024.

$2,026in general payments, 2019–2025

Across 145 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$639
  • Novo Nordisk$266
  • Takeda Pharmaceuticals U.S.A., Inc.$163
  • AstraZeneca$146
  • GSK$119
  • Eisai Inc.$109
  • plus $584 from 18 others

What the payments were for

  • Food & beverage$2,00699%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,026 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois →

Other family in Vandalia

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →